PUNE, India, November 24, 2015 /PRNewswire/ --
According to a new market research report "Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, Custom Oligos, Reagent, Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global Forecast to 2020", published by MarketsandMarkets, the market is expected to reach USD 1,918.6 Million by 2020 from USD 1,078.1 Million in 2015, at a CAGR of 10.1% during the forecast period.
Browse 183 market data Tables and 53 Figures spread through 229 Pages and in-depth TOC on "Oligonucleotide Synthesis Market"
Early buyers will receive 10% customization on this report.
Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, Custom Oligos, Reagent, Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global Forecast to 2020 analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
In this report, the Oligonucleotide Synthesis Market is segmented based on products and services, applications, end users, and regions. On the basis of products and services, the Oligonucleotide Synthesis Market is segmented into synthesized oligonucleotides, reagents, and equipment.
Synthesized oligonucleotides are expected to account for the largest share of the Oligonucleotide Synthesis Market in 2015. Growth in this segment is attributed to the increasing number of applications of synthesized oligonucleotides in research, diagnostics, and therapeutics. The rising demand for custom oligos also contributes to the growth of the synthesized oligonucleotides market.
Among applications, the research applications segment dominates the market, whereas the diagnostic applications segment is expected to grow at the highest CAGR during the forecast period. Among end users, the diagnostic laboratories segment is expected to grow at the highest CAGR during the forecast period. On the basis of regions, the Oligonucleotide Synthesis Market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is expected to account for the largest share of this market in 2015. However, APAC is expected to grow at the highest CAGR during the forecast period, owing to the growing availability of synthesized oligos, increase in R&D funding and activities, and increasing focus of prominent players in in the APAC region.
Get The PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=200829350
The Oligonucleotide Synthesis Market is highly competitive, with the presence of several big as well as emerging market players. In addition, each product segment has a different set of vendors. Key market players include Agilent Technologies (U.S.), BioAutomation Corporation (U.S.), Biosearch Technologies, Inc. (U.S.), Eurofins Genomics (Germany), Eurogentec (Belgium), GeneDesign, Inc. (Japan), GE Healthcare (U.K.), Integrated DNA Technologies (IDT) (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), TriLink BioTechnologies, Inc. (U.S.), Gen9, Inc. (U.S.), GenScript (U.S.), and Nitto Denko Avecia Inc. (Japan).
Browse Related Reports:
Synthetic Biology Market by Tool(XNA, Chassis, Oligos, Enzymes, Cloning kits), By Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning & Sequencing), By Application (Biofuels, Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to 2018
Next Generation Sequencing (NGS) Market by Platforms (Illumina HiSeq, MiSeq, HiSeqX Ten, NextSeq 500,Thermo Fisher Ion Proton/PGM), Bioinformatics (Exome Sequencing, RNA-Seq, ChIP-Seq), Technology (SBS, SMRT) & by Application (Diagnostics, Personalized Medicine) - Global Forecast to 2020.
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune - 411013,
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets